Literature DB >> 19375583

Effects of alpha-lipoic acid on transforming growth factor beta1-p38 mitogen-activated protein kinase-fibronectin pathway in diabetic nephropathy.

Seong Jin Lee1, Jun Goo Kang, Ohk Hyun Ryu, Chul Sik Kim, Sung-Hee Ihm, Moon Gi Choi, Hyung Joon Yoo, Dong-Sun Kim, Tae Wha Kim.   

Abstract

In diabetic nephropathy, transforming growth factor beta1 (TGFbeta1) is related to p38 mitogen-activated protein kinase (MAPK) that induces production of fibronectin in mesangial cells. We investigated the effects of alpha-lipoic acid (ALA), a potent antioxidant, on proteinuria and TGFbeta1-p38 MAPK-fibronectin pathway in diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. After ALA treatment for 5 weeks in OLETF rats at 30 weeks of age, plasma malondialdehyde, urinary protein excretion, renal cortical TGFbeta1, and fibronectin protein levels were decreased; and urinary protein excretion was positively correlated with renal cortical TGFbeta1 and fibronectin protein levels. Phospho-form but not total-form levels as well as fold activations of each protein consisting of p38 MAPK pathway were also attenuated. These results suggest that ALA ameliorates proteinuria by attenuating expressions of TGFbeta1 and fibronectin proteins, and these favorable effects are related to inhibition of phosphorylating activation of p38 MAPK pathway in renal cortex of OLETF rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375583     DOI: 10.1016/j.metabol.2008.12.006

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

1.  Epithelial Sodium Channel in Aldosterone-Induced Endothelium Stiffness and Aortic Dysfunction.

Authors:  Guanghong Jia; Javad Habibi; Annayya R Aroor; Michael A Hill; Yan Yang; Adam Whaley-Connell; Frederic Jaisser; James R Sowers
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

Review 2.  Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.

Authors:  Guanghong Jia; Michael A Hill; James R Sowers
Journal:  Circ Res       Date:  2018-02-16       Impact factor: 17.367

3.  Reduced expression of lipoic acid synthase accelerates diabetic nephropathy.

Authors:  Xianwen Yi; Longquan Xu; Sylvia Hiller; Hyung-Suk Kim; Volker Nickeleit; Leighton R James; Nobuyo Maeda
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

4.  Zinc delays the progression of obesity-related glomerulopathy in mice via down-regulating P38 MAPK-mediated inflammation.

Authors:  Manyu Luo; Ping Luo; Zhiguo Zhang; Kristen Payne; Sara Watson; Hao Wu; Yi Tan; Yushuang Ding; Weixia Sun; Xinmin Yin; Xiang Zhang; Gilbert Liu; Kupper Wintergerst; Lining Miao; Lu Cai
Journal:  Obesity (Silver Spring)       Date:  2016-03-29       Impact factor: 5.002

Review 5.  Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Xin Mou; Di-Yi Zhou; Dan-Yang Zhou; Jing-Ru Ma; Ying-Hui Liu; Hui-Ping Chen; Yong-Bin Hu; Cheng-Min Shou; Jia-Wei Chen; Wen-Hong Liu; Guo-Ling Ma
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

6.  α-Lipoic acid prevents the intestinal epithelial monolayer damage under heat stress conditions: model experiments in Caco-2 cells.

Authors:  Soheil Varasteh; Johanna Fink-Gremmels; Johan Garssen; Saskia Braber
Journal:  Eur J Nutr       Date:  2017-03-27       Impact factor: 5.614

7.  ALA/LA ameliorates glucose toxicity on HK-2 cells by attenuating oxidative stress and apoptosis through the ROS/p38/TGF-β1 pathway.

Authors:  Mingxia Jiang; Haifen Zhang; Lijie Zhai; Bianliang Ye; Yin Cheng; Chengkai Zhai
Journal:  Lipids Health Dis       Date:  2017-11-16       Impact factor: 3.876

8.  Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.

Authors:  Youzi Dong; Quanlin Zhao; Yuguo Wang
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

Review 9.  Mitochondrial Dysfunction in Diabetic Cardiomyopathy: The Possible Therapeutic Roles of Phenolic Acids.

Authors:  Fatin Farhana Jubaidi; Satirah Zainalabidin; Vanitha Mariappan; Siti Balkis Budin
Journal:  Int J Mol Sci       Date:  2020-08-22       Impact factor: 5.923

Review 10.  CD36 Signaling in Diabetic Cardiomyopathy.

Authors:  Xudong Zhang; Jiahui Fan; Huaping Li; Chen Chen; Yan Wang
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.